Zoono Group’s (ASX:ZNO) Share Price Zooms 13% on ASX. Here’ Why

  • October 29, 2020 04:39 PM AEDT
  • Team Kalkine
    Team Kalkine
    Team Kalkine
    16991 Posts

    Team Kalkine comprises of experts who understand various markets nuances and are enthusiastic and passionate to provide best possible offerings in the form of insights and stories. The team has rich experience of working across different markets with...

Zoono Group’s (ASX:ZNO) Share Price Zooms 13% on ASX. Here’ Why

Summary

  • Zoono Group Limited has announced that its recent tests conducted on UK passenger trains confirmed the efficacy of its Microbe Shield against pathogens.
  • 72 hot touchpoint areas across 23 UK passenger trains were treated with Microbe Shield between 8-30 days before testing the efficiency.
  • The results demonstrated no presence of COVID-19 and E.coli in all 72 tests and detected Staphylococcus in two of the tests.

The share price of Zoono Group Limited (ASX:ZNO) surged on the ASX today following the Company’s announcement that its latest tests confirmed the efficacy of its Microbe Shield sanitiser against pathogens. The shares of ZNO ended the day’s session 13.380% higher at A$1.610 on 29 October 2020.

Let us discuss in detail-

Zoono Group Confirms Efficacy and Longevity of Microbe Shield

ASX-listed global biotech player Zoono Group Limited is engaged in the development and distribution of long-lasting and environment-friendly antimicrobial solutions.

On 29 October 2020, Zoono Group Limited provided an update of recent test results on its products from a series of independent laboratory tests. The results validated the efficacy and longevity of Zoono’s surface sanitiser, Microbe Shield against pathogens.

The Company highlighted that in the UK, a series of in-situ tests were conducted on passenger trains servicing UK Rail. Zoono disclosed that the recent testing was conducted collaboratively by GTECH Strategies Limited and an independent UKAS-accredited test laboratory.

During the tests, 72 hot touchpoints areas were assessed in 23 trains for Human COVID-19, E.coli and Staphylococcus. These hot points had been sprayed with Microbe Shield between 8-30 days before testing.

The independent laboratory highlighted the following outcomes-

Moreover, the Company disclosed that-

  • The UAE government appointed Lab confirms 99.9% efficacy of Zoono Microbe Shield within 30 days.
  • Intertek Laboratory’s testing shows Zoono Microbe Shield >99.99% efficacy at 30 days.
  • The testing demonstrates alcohol-free hand sanitiser of GermFree24 meets all the needs of the EN1500 standard for hygienic hand rubs.
  • Zoono recently commissioned additional testing against E-coli to a European standard of Zoono’s Hand Alcohol-Free Sanitiser GermFree24 by Lab-Test Laboratorium S.C, Poland. Outcomes showed that it meets the requirements of the EN1500 standard for hygienic hand rubs.

Bottomline

Zoono Group remains under the spotlight driven by its antimicrobial solution that has proven to be over 99% effective against SARS-CoV-2. Today’s validation of the efficacy and longevity of Microbe Shield boosts the Company’s confidence regarding the potential for its surface santiser.

 

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK